Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy-Reference-Cited by-同舟云学术

Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy

Published:2006-01 Issue:1 Volume:118 Page:77-82
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Caggiula Marcella,Batocchi Anna Paola,Frisullo Giovanni,Angelucci Francesco,Patanella Agata Katia,Sancricca Cristina,Nociti Viviana,Tonali Pietro Attilio,Mirabella Massimiliano

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference28 articles.

1. Current approved options for treating patients with multiple sclerosis;Rizvi;Neurology,2004

2. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial;Filippi;Lancet,2004

3. Interferon-beta-1b slows progression of atrophy in RRMS: three-year follow-up in NAb− and NAb+ patients;Frank;Neurology,2004

4. A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis;Zhang;Clin. Ther.,2002

5. Interferon-beta is a potent promoter of nerve growth factor production by astrocytes;Boutros;J. Neurochem.,1997

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relevance of BDNF for neuroprotection and neuroplasticity in multiple sclerosis;Frontiers in Neurology;2024-08-01

2. Nerve Growth Factor and Autoimmune Diseases;Current Issues in Molecular Biology;2023-11-10

3. Methyl-CpG-Binding Protein 2 Emerges as a Central Player in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders;Cellular and Molecular Neurobiology;2023-11

4. The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement;Frontiers in Neurology;2022-11-10

5. Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis;International Journal of Molecular Sciences;2022-10-12